297 related articles for article (PubMed ID: 11439347)
1. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
Scheel C; Schaefer KL; Jauch A; Keller M; Wai D; Brinkschmidt C; van Valen F; Boecker W; Dockhorn-Dworniczak B; Poremba C
Oncogene; 2001 Jun; 20(29):3835-44. PubMed ID: 11439347
[TBL] [Abstract][Full Text] [Related]
2. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
3. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Ulaner GA; Huang HY; Otero J; Zhao Z; Ben-Porat L; Satagopan JM; Gorlick R; Meyers P; Healey JH; Huvos AG; Hoffman AR; Ladanyi M
Cancer Res; 2003 Apr; 63(8):1759-63. PubMed ID: 12702558
[TBL] [Abstract][Full Text] [Related]
4. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
[TBL] [Abstract][Full Text] [Related]
5. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
[TBL] [Abstract][Full Text] [Related]
6. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
7. Telomere lengthening in telomerase-negative cells: the ends are coming together.
Scheel C; Poremba C
Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
[TBL] [Abstract][Full Text] [Related]
8. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
9. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
10. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
[TBL] [Abstract][Full Text] [Related]
11. Telomerase expression predicts unfavorable outcome in osteosarcoma.
Sanders RP; Drissi R; Billups CA; Daw NC; Valentine MB; Dome JS
J Clin Oncol; 2004 Sep; 22(18):3790-7. PubMed ID: 15365076
[TBL] [Abstract][Full Text] [Related]
12. Alternative lengthening of telomeres frequently occurs in mismatch repair system-deficient gastric carcinoma.
Omori Y; Nakayama F; Li D; Kanemitsu K; Semba S; Ito A; Yokozaki H
Cancer Sci; 2009 Mar; 100(3):413-8. PubMed ID: 19154407
[TBL] [Abstract][Full Text] [Related]
13. Telomere dysfunction drives chromosomal instability in human mammary epithelial cells.
Soler D; Genescà A; Arnedo G; Egozcue J; Tusell L
Genes Chromosomes Cancer; 2005 Dec; 44(4):339-50. PubMed ID: 16052508
[TBL] [Abstract][Full Text] [Related]
14. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
15. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
[TBL] [Abstract][Full Text] [Related]
16. Expression of human telomerase reverse transcriptase splice variants is well correlated with low telomerase activity in osteosarcoma cell lines.
Fujiwara-Akita H; Maesawa C; Honda T; Kobayashi S; Masuda T
Int J Oncol; 2005 Apr; 26(4):1009-16. PubMed ID: 15753996
[TBL] [Abstract][Full Text] [Related]
17. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
18. Immortalized cells with no detectable telomerase activity. A review.
Reddel RR; Bryan TM; Murnane JP
Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
[TBL] [Abstract][Full Text] [Related]
19. Multiple mechanisms of telomere maintenance exist in liposarcomas.
Johnson JE; Varkonyi RJ; Schwalm J; Cragle R; Klein-Szanto A; Patchefsky A; Cukierman E; von Mehren M; Broccoli D
Clin Cancer Res; 2005 Aug; 11(15):5347-55. PubMed ID: 16061847
[TBL] [Abstract][Full Text] [Related]
20. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Nittis T; Guittat L; Stewart SA
Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
